EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study

Takehito Shukuya iD, Kazuhisa Takahashi, Yasushi Shintani, Keita Miura, Ikuo Sekine, Koichi Takayama, Akira Inoue, Isamu Okamoto, Katsuyuki Kiura, Tomoya Kawaguchi, Nobuyuki Yamamoto, Etsuo Miyaoka und 2 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2023-06 · 14 (3) · 1274-1285

DOI: 10.1002/jcsm.13216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 10.03.2023. Verfasst von Takehito Shukuya und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer cachexia is a syndrome that does not fully recover with nutritional support and causes appetite loss and body weight loss. It worsens a patient's quality of life and prognosis. In this study, the epidemiology of cachexia in lung cancer, its risk factors and its impact on chemotherapy response rate and prognosis were examined using the national database of the Japan Lung Cancer Society. Understanding these things related to cancer cachexia is important as a starting point in overcoming cancer cachexia in patients with lung cancer.

Methods

In 2012, 12 320 patients from 314 institutions in Japan were registered in a nationwide registry database (Japanese Lung Cancer Registry Study). Of these, data on body weight loss within 6 months were available for 8489 patients. We defined the patients with body weight loss ≥ 5% within 6 months, which is one of the three criteria listed in the 2011 international consensus definition of cancer cachexia, as cachectic in this study.

Results

Approximately 20.4% of the 8489 patients had cancer cachexia. Sex, age, smoking history, emphysema, performance status, superior vena cava syndrome, clinical stage, site of metastasis, histology, epidermal growth factor receptor ( EGFR ) mutation status, primary treatment method and serum albumin levels were significantly different between patients with and without cachexia. Logistic analyses showed that smoking history, emphysema, clinical stage, site of metastasis, histology, EGFR mutation, serum calcium and albumin levels were significantly associated with cancer cachexia. The response to initial therapy, including chemotherapy, chemoradiotherapy or radiotherapy, was significantly poorer in the patients with cachexia than in those without cachexia (response rate: 49.7% vs. 41.5%, P < 0.001). Overall survival was significantly shorter in the patients with cachexia than in those without cachexia in both univariate and multivariable analyses (1‐year survival rate: 60.7% vs. 37.6%, Cox proportional hazards model, hazard ratio: 1.369, 95% confidence interval: 1.274–1.470, P < 0.001).

Conclusions

Cancer cachexia was seen in approximately one fifth of the lung cancer patients and was related to some baseline patient characteristics. It was also associated with a poor response to initial treatment, resulting in poor prognosis. The results of our study may be useful for early identification and intervention in patients with cachexia, which may improve their response to treatment and their prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansCachexiaEast Asian PeopleErbB ReceptorsQuality of LifeRisk FactorsSuperior Vena Cava Syndrome

Stichwörter der Autor:innen

body weight losscancer cachexiachemotherapylung cancerrisk factorsurvival

Substanzen

ErbB Receptors

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

ORCID-Profile: Takehito Shukuya

Zitieren

APA

Shukuya, T., Takahashi, K., Shintani, Y., Miura, K., Sekine, I., Takayama, K., Inoue, A., Okamoto, I., Kiura, K., Kawaguchi, T., Yamamoto, N., Miyaoka, E., Yoshino, I., & Date, H. (2023). Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1274-1285. https://doi.org/10.1002/jcsm.13216

Vancouver

Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, et al. Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(3):1274-1285. doi:10.1002/jcsm.13216

BibTeX
@article{Shukuya2023,
  author = {Shukuya, Takehito and Takahashi, Kazuhisa and Shintani, Yasushi and Miura, Keita and Sekine, Ikuo and Takayama, Koichi and Inoue, Akira and Okamoto, Isamu and Kiura, Katsuyuki and Kawaguchi, Tomoya and Yamamoto, Nobuyuki and Miyaoka, Etsuo and Yoshino, Ichiro and Date, Hiroshi},
  title = {Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  volume = {14},
  number = {3},
  pages = {1274--1285},
  doi = {10.1002/jcsm.13216}
}
Kostenlos starten →